| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 0.2 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.2 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.035 | 0.2 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.2 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |